Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amplyx Raises $67m For Antifungals Against Life-Threatening Pathogens

Aug 02 2017

• By Mandy Jackson

trading

Related Content

Antibiotic Development: Limited Population Pathway In US Removes Barrier

Mar 29 2017

AMR Roundtable Part 1: Incentives Spur Antimicrobial Investments, But More Needed

Jul 14 2017

Early February VC Tally: 6 Biotech Firms Raise $153.5m

Feb 10 2016

Better Incentives Needed For Worsening Fungal Infection Threat

Jun 29 2017

Related Companies

Amplyx Pharmaceuticals, Inc.

Additional Topics

Financing StartUps and SMEs Business Strategies Innovation Commercial Infectious Diseases BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window